•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Ovid Therapeutics Inc. (OVID) Presents at UBS Global Biopharma Conference 2026 Prepared Remarks Transcript
Ovid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results
Critical Comparison: Ovid Therapeutics (NASDAQ:OVID) & Ono Pharmaceutical (OTCMKTS:OPHLF)
Ovid Therapeutics to Participate in Upcoming Investor Conferences
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
Ovid Therapeutics to Participate in Upcoming Investor Conferences
BlackRock Inc. Takes Position in Ovid Therapeutics $OVID
What Makes Ovid Therapeutics (OVID) a Strong Momentum Stock: Buy Now?
Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
Earnings Preview: Ovid Therapeutics (OVID) Q2 Earnings Expected to Decline
Ally Bridge Group NY LLC Has $6.26 Million Position in Ovid Therapeutics $OVID
ADAR1 Capital Management LLC Acquires 259,113 Shares of Ovid Therapeutics $OVID
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally
Ovid Therapeutics: Buy Next-Gen GABA-Aminotransferase Inhibitor OV329 And TSC/IS Expansions
Ovid Therapeutics to Participate in Upcoming Investor Conferences
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials